Application
Western blot analysis of DLX2 Antibody (Center) in 293 cell line lysates (35ug/lane). DLX2 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human brain tissue reacted with DLX2 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | DLX2 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | DLX2; Homeobox protein DLX-2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | DLX2 Homeobox protein DLX-2 |
|---|---|
| Molecular Weight(MW) | 34243 Da |
| Function | Likely to play a regulatory role in the development of the ventral forebrain. May play a role in craniofacial patterning and morphogenesis |
| Tissue Specificity | This DLX2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 201~230 amino acids from the Center region of human DLX2. |
| Cellular Localization | Nucleus (Potential). |
| Entrez Gene | 1746 |
|---|
Application
Western blot analysis of DLX2 Antibody (Center) in 293 cell line lysates (35ug/lane). DLX2 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human brain tissue reacted with DLX2 Antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
